/CRTX.L
CRTX.L Stock - CRISM Therapeutics Corporation
Healthcare|BiotechnologyLSE
$9.50+0.00%
+$0.00 (+0.00%) • Dec 22
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.6
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $10.45
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CRTX.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$9.40 – $9.60
TARGET (TP)$10.92
STOP LOSS$8.74
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.34
52W High$29.40
52W Low$5.64
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $25,000 | $57,366 | N/A | N/A | N/A |
| Gross Profit | $21,000 | $16,572 | N/A | N/A | $-3,899 |
| Gross Margin | 84.0% | 28.9% | N/A | N/A | N/A |
| Operating Income | $-582,000 | $-2,259,000 | $-2,224,000 | $-1,300,080 | $-3,083,000 |
| Net Income | $-607,000 | $-9,647,000 | $-2,446,053 | $-1,542,204 | $-2,080,547 |
| Net Margin | -2428.0% | -16816.6% | N/A | N/A | N/A |
| EPS | $-0.10 | $-0.07 | $-0.28 | $-0.18 | $-0.31 |
Company Overview
CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CRTX.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2024
EPS Surprise History
Q4 20
No data
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 9, 2025 | — | — | — | — |
Q3 2024 | Sep 19, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 10, 2024 | — | $-0.05 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.26 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.13 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-0.21 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.27 | — | — |
Q2 2021 | Jun 29, 2021 | — | $0.03 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.14 | — | — |
Q2 2020 | Jun 29, 2020 | — | $-0.27 | — | — |
Q4 2019 | Dec 30, 2019 | — | $-0.21 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.00 | — | — |
Q4 2018 | Dec 30, 2018 | — | $-0.38 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.38 | — | — |
Q4 2017 | Dec 30, 2017 | — | $-0.16 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.16 | — | — |
Q4 2016 | Dec 30, 2016 | — | $-0.77 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.77 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CRTX.L
What is CRTX.L's current stock price?
CRISM Therapeutics Corporation (CRTX.L) is currently trading at $9.50 per share. The stock has moved +0.00% today.
What is the analyst price target for CRTX.L?
No analyst price targets are currently available for this stock.
What sector is CRISM Therapeutics Corporation in?
CRISM Therapeutics Corporation operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the LSE exchange.
What is CRTX.L's market cap?
CRISM Therapeutics Corporation has a market capitalization of $0.00 billion, making it a small-cap company.
Does CRTX.L pay dividends?
No, CRISM Therapeutics Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCHLL.L
Chill Brands Group PLC
$0.78
Mkt Cap: $0.4B
CIZ.L
Cizzle Biotechnology Holdings Plc
$1.55
Mkt Cap: $0.6B
FDBK.L
Feedback plc
$8.00
Mkt Cap: $0.4B
MHC.L
MyHealthChecked PLC
$8.75
Mkt Cap: $0.5B
N4P.L
N4 Pharma Plc
$0.53
Mkt Cap: $0.4B
OBD.L
Oxford BioDynamics Plc
$0.23
Mkt Cap: $0.5B
PRM.L
Proteome Sciences plc
$2.35
Mkt Cap: $0.7B
ROQ.L
Roquefort Therapeutics plc
$1.30
Mkt Cap: $0.2B
TCF.L
Theracryf Plc
$0.20
Mkt Cap: $0.4B
TRX.L
Tissue Regenix Group plc
$7.25
Mkt Cap: $0.5B
Explore stocks similar to CRTX.L for comparison